JournalsHub
.online
Find My Journal
JB

Jean‐Claude Becker

Pfizer (United States) US

29
Publications
5,691
Citations
18
H-Index
18
i10-Index
0
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Most Cited Works

Abatacept for Rheumatoid Arthritis Refractory to Tumor Necrosis Factor α Inhibition OA
Mark C. Genovese, Jean‐Claude Becker, Michael Schiff, Michael E. Luggen, Yvonne Sherrer +9 more
New England Journal of Medicine 2005
1,240
Treatment of Rheumatoid Arthritis by Selective Inhibition of T-Cell Activation with Fusion Protein CTLA4Ig OA
Joel M. Kremer, René Westhovens, Marc Léon, Eduardo Di Giorgio, Rieke Alten +9 more
New England Journal of Medicine 2003
1,053
Effects of Abatacept in Patients with Methotrexate-Resistant Active Rheumatoid Arthritis
Joel M. Kremer, Harry K. Genant, Larry W. Moreland, Anthony S. Russell, Paul Emery +6 more
Annals of Internal Medicine 2006
713
Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: Twelve‐month results of a phase iib, double‐blind, randomized, placebo‐controlled trial OA
Joel M. Kremer, Maxime Dougados, Paul Emery, Patrick Durez, Jean Sibilia +8 more
Arthritis & Rheumatism 2005
446
Safety of the selective costimulation modulator abatacept in rheumatoid arthritis patients receiving background biologic and nonbiologic disease‐modifying antirheumatic drugs: A one‐year randomized, placebo‐controlled study OA
Michael E. Weinblatt, Bernard Combe, A. Covucci, R. Aranda, Jean‐Claude Becker +1 more
Arthritis & Rheumatism 2006
383

Publications

27 total

A phase I pharmacokinetics trial comparing PF‐05280586 (a potential biosimilar) and rituximab in patients with active rheumatoid arthritis PDF

Stanley Cohen, Paul Emery, Maria Greenwald, Donghua Yin, Jean‐Claude Becker et al. - British Journal of Clinical Pharmacology, 2016
Cited by 52 OpenAlex

Long-term safety, efficacy and inhibition of radiographic progression with abatacept treatment in patients with rheumatoid arthritis and an inadequate response to methotrexate: 3-year results from the AIM trial PDF

Joel M. Kremer, Anthony S. Russell, Paul Emery, Carlos Abud‐Mendoza, Jacek Szechiński et al. - Annals of the Rheumatic Diseases, 2011
Cited by 144 OpenAlex

The efficacy and safety of abatacept in patients with non–life‐threatening manifestations of systemic lupus erythematosus: Results of a twelve‐month, multicenter, exploratory, phase IIb, randomized, double‐blind, placebo‐controlled trial PDF

Joan T. Merrill, Rubén Burgos‐Vargas, René Westhovens, Andrew Chalmers, David D’Cruz et al. - Arthritis & Rheumatism, 2010
Cited by 374 OpenAlex

Abatacept in the treatment of patients with psoriatic arthritis: Results of a six‐month, multicenter, randomized, double‐blind, placebo‐controlled, phase II trial

Philip J. Mease, Mark C. Genovese, Geoffrey Gladstein, Alan Kivitz, Christopher T. Ritchlin et al. - Arthritis & Rheumatism, 2010
Cited by 298 OpenAlex

Safety and Efficacy of the Selective Costimulation Modulator Abatacept in Patients with Rheumatoid Arthritis Receiving Background Methotrexate: A 5-year Extended Phase IIB Study PDF

René Westhovens, Joel M. Kremer, Larry W. Moreland, Paul Emery, Anthony S. Russell et al. - The Journal of Rheumatology, 2009
Cited by 122 OpenAlex

Results of a two‐year followup study of patients with rheumatoid arthritis who received a combination of abatacept and methotrexate

Joel M. Kremer, Harry K. Genant, Larry W. Moreland, Anthony S. Russell, Paul Emery et al. - Arthritis & Rheumatism, 2008
Cited by 174 OpenAlex

Effects of Abatacept in Patients with Methotrexate-Resistant Active Rheumatoid Arthritis

Joel M. Kremer, Harry K. Genant, Larry W. Moreland, Anthony S. Russell, Paul Emery et al. - Annals of Internal Medicine, 2006
Cited by 713 OpenAlex

Safety of the selective costimulation modulator abatacept in rheumatoid arthritis patients receiving background biologic and nonbiologic disease‐modifying antirheumatic drugs: A one‐year randomized, placebo‐controlled study PDF

Michael E. Weinblatt, Bernard Combe, A. Covucci, R. Aranda, Jean‐Claude Becker et al. - Arthritis & Rheumatism, 2006
Cited by 383 OpenAlex

Reduction of inflammatory biomarker response by abatacept in treatment of rheumatoid arthritis.

Michael H. Weisman, Patrick Durez, David S. Hallegua, Richard Aranda, Jean‐Claude Becker et al. - PubMed, 2006
Cited by 100 OpenAlex

Treatment of rheumatoid arthritis patients with abatacept and methotrexate significantly improved health-related quality of life. PDF

Paul Emery, Mark Kosinski, Tracy Li, Marie C. Martin, Glennis Williams et al. - PubMed, 2006
Cited by 67 OpenAlex

Research Topics

Rheumatoid Arthritis Research and Therapies (20) Spondyloarthritis Studies and Treatments (11) Autoimmune and Inflammatory Disorders Research (8) Biosimilars and Bioanalytical Methods (6) Venous Thromboembolism Diagnosis and Management (3)

Frequent Co-Authors

PA
Paul Emery
8 joint publications
TR
Tracy Li
7 joint publications
LA
Larry W. Moreland
7 joint publications
JO
Joel M. Kremer
6 joint publications
RE
René Westhovens
6 joint publications
AN
Anthony S. Russell
6 joint publications

Affiliations

Bristol-Myers Squibb (Germany)
DE 2011 - 2005
Pfizer (United States)
US 2018 - 2014
University of Alberta Hospital
CA 2006 - 2006
Bristol-Myers Squibb (United States)
US 2011 - 2002
Bristol-Myers Squibb (Sweden)
SE 2007 - 2007

External Profiles

OpenAlex Profile Search Semantic Scholar Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now